G9207 – Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

Long description

Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

Short description

Hep c genotype prior to med

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

M5B Specialist - psychiatry

Added

January 1, 2014

Last change

January 1, 2017 – No change

Termination date

December 31, 2016

Nearby G codes

• G9199 – Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))
• G9200 – Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given
• G9201 – Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission
• G9202 – Patients with a positive hepatitis c antibody test
• G9203 – Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
• G9204 – Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
• G9205 – Patient starting antiviral treatmentfor hepatitis c during the measurement period
• G9206 – Patient starting antiviral treatment for hepatitis c during the measurement period
• G9208 – Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
• G9209 – Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment
• G9210 – Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)
• G9211 – Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given
• G9212 – Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
• G9213 – Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified
• G9214 – Cd4+ cell count or cd4+ cell percentage results documented
• G9215 – Cd4+ cell count or percentage not documented as performed, reason not given